• LinkedIn
SFL Regulatory Affairs & Scientific Communication Ltd.
  • About SFL
    • Why SFL
    • Team
    • Associations
    • History
    • Awards
    • Ethics
  • Services
    • Regulatory Affairs
    • Quality Assurance & GxP Compliance
    • Medical Affairs & Communication
    • Market Access & Reimbursement
    • Public Affairs & Regulatory Intelligence
    • Medical Devices, Combination Products and IVDs
    • Pharmacovigilance & Clinical Safety
    • Supply Chains of Medicines and Devices
    • Legal & Healthcare Compliance
    • Swiss Support
    • UK Support
    • Clinical Trials support
  • Clients
    • Testimonials
    • Cases
  • Trainings
    • Customized training
    • Webinars
  • News
    • News
    • Newsletter
  • Careers
  • Contact
  • Search
  • Menu Menu

SFL offers on 28 November 2019 a 1-hour free webinar on the Revised Swiss Therapeutic Products Act & Ordinances

The revised Swiss Therapeutic Products Act (TPA) and its related ordinances entered into force on 1 January 2019. The modifications aim at creating new and simpler access opportunities for certain medicinal product categories, improving drug safety and enhancing transparency by increasing the scope of the information published by Swissmedic.

This webinar will address important changes and implications for industry

  • Art. 13
  • Simplified authorisation procedure
  • Temporary marketing authorisation
  • Paediatric Investigation Plan
  • Orphan drugs and data protection
  • Increase of transparency
  • SwissPAR

For more information and registration click here.

  • News
  • Newsletter

Switzerland – Main Office

SFL Regulatory Affairs & Scientific Communication GmbH
Aeschenvorstadt 52 | CH-4051 Basel
Email: office@sfl-services.com
Phone: +41 61 361 9443

© Copyright 2023 - SFL Regulatory Affairs & Scientific Communication GmbH | Terms and Conditions | Privacy Statement | Cookies Policy
Scroll to top